112 related articles for article (PubMed ID: 3334612)
1. Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.
Westenfelder M; Frankenschmidt A; Pelz K
Chemioterapia; 1987 Jun; 6(2 Suppl):515-6. PubMed ID: 3334612
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection].
Sonoda T; Nakano E; Seguchi T; Yano H; Kuroda H; Ihara Y; Kishimoto T; Takatera H; Mizutani S; Iwao N
Hinyokika Kiyo; 1991 Feb; 37(2):203-9. PubMed ID: 2048503
[TBL] [Abstract][Full Text] [Related]
3. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
[No Abstract] [Full Text] [Related]
4. Carumonam in the treatment of severe and complicated urinary tract infections.
Kotilainen P; Huovinen P; Hänninen P
Chemioterapia; 1987 Jun; 6(2 Suppl):514-5. PubMed ID: 3509487
[No Abstract] [Full Text] [Related]
5. Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.
Hahn LB; Iribarren M; Barclay C; Casellas J; Traballi C; Farinati A
Chemioterapia; 1987 Jun; 6(2 Suppl):519-21. PubMed ID: 3334614
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of aztreonam for complicated urinary tract infection].
Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
[TBL] [Abstract][Full Text] [Related]
8. [Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
Kohri K; Kurita T; Sakaguti H; Kadowaki T; Iguti M; Kanda H; Nagi N; Kataoka K; Kawamura M; Mitsubayashi S
Hinyokika Kiyo; 1989 Apr; 35(4):711-6. PubMed ID: 2660527
[TBL] [Abstract][Full Text] [Related]
9. [Comparative multicenter study between aztreonam and gentamycin in the treatment of renal and urinary infections].
Albertazzi A; Bonadio M; Fusaroli M; Miano L; Lotti T; Salvia G; Sasdelli M; Villa G; Zucchelli P
G Ital Chemioter; 1985; 32(2):465-8. PubMed ID: 3914436
[No Abstract] [Full Text] [Related]
10. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
Fraschini F; Scaglione F; Alessandria M; Gattei G
Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo experience with carumonam: a preliminary report.
Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H
J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334
[No Abstract] [Full Text] [Related]
12. [Aztreonam vs norfloxacin: a comparative study of the treatment of urinary tract infections in ambulatory and hospitalized patients].
Puppo P; Germinale F; De Rose AF
Clin Ter; 1989 Apr; 129(2):113-21. PubMed ID: 2525996
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the effectiveness and renal tolerance of aztreonam (1 daily dosage) and gentamycin (2 daily doses) in the therapy of renal and urinary infections].
Bonadio M; Maccanti O; Pulitanò L; Galigani P; Palla R
G Ital Chemioter; 1985; 32(2):459-63. PubMed ID: 3914435
[No Abstract] [Full Text] [Related]
14. [Rational antibiotic therapy of urinary tract infections].
Wagenlehner FM; Naber KG; Weidner W
Med Monatsschr Pharm; 2008 Oct; 31(10):385-90; quiz 391-2. PubMed ID: 18972869
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of azthreonam in severe urinary tract infections].
Guibert J; Acar JF; Miegi M
Pathol Biol (Paris); 1984 May; 32(5):446-9. PubMed ID: 6377208
[TBL] [Abstract][Full Text] [Related]
16. Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
Hoepelman AI; Bakker LJ; Verhoef J
Antimicrob Agents Chemother; 1988 Apr; 32(4):473-6. PubMed ID: 3377459
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of cefotiam (CGP/14221) versus cephalothin in the treatment of urinary tract infections.
Tselentis J; Cordossis T; Eliopoulos G
Pharmatherapeutica; 1983; 3(6):382-7. PubMed ID: 6312460
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
[TBL] [Abstract][Full Text] [Related]
19. Carumonam versus ceftazidime for urinary tract infections.
Edelstein H; Oster S; Cassano K; McCabe R
Antimicrob Agents Chemother; 1988 Jul; 32(7):1031-3. PubMed ID: 3056245
[TBL] [Abstract][Full Text] [Related]
20. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
